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ABSTRACT
We present the case of a 58-year-old Japanese woman 
with a natural killer T (NK/T)-cell lymphoma com-
plicated by brain abscess. NK/T-cell lymphomas 
represent a rare type of lymphoma derived from either 
activated NK cells or, rarely, cytotoxic T cells. They 
are aggressive Epstein-Barr virus (EBV)-associated 
lymphomas that involve mainly the nasal cavity. Brain 
abscess associated with primary extranodal nasal-
type NK/T-cell lymphoma is extremely uncommon: 
to our knowledge, this is the first reported case of this 
lymphoma with brain abscess as the initial clinical 
manifestation. Endoscopic surgery was performed for 
definitive diagnosis under intraoperative navigation 
system. Chemotherapy followed by radiotherapy was 
performed and was effective: 72 months later the tumor 
has not recurred. Recommendations of endoscopic 
management for diagnosis and treatment of this rare 
neoplasm are discussed.
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Extranodal natural killer (NK/T)-cell lymphoma, nasal 
type, is an aggressive lymphoma that was originally 
described to involve the midline facial area, mainly 
the nasal cavity. The nasal cavity is, by far, the most 
common and prototypic site of involvement, but other 
primary sites have been reported, including the para-
nasal sinuses, pharynx, skin, gastrointestinal tract, and 
testis. Although there have been isolated cases involving 
the brain, none of these reports has been convincing 
for brain abscess involvement as initial clinical mani-
festation. Here we report a case of extranodal NK/T 
lymphoma with brain abscess.
PATIENT REPORT
A 58-year-old Japanese woman was admitted to our 
hospital with the chief complaint of frontal headache 
and nasal obstruction for a period of approximately 1 
month. Repeated biopsies from a right-side nasal mass 
had been performed at another hospital but had revealed 
only necrotic tissue, with no neoplastic cells. Endoscopy 
showed a white-coated necrotic mass in the right nasal 
cavity (Fig. 1). Coronal and axial computed tomography 
showed a soft-tissue-density mass in the right frontal, 
maxillary, sphenoid, and ethmoid sinuses and the right 
nasal cavity. The orbital medial wall, the nasal septum, 
and the frontal skull base had been destroyed by the 
tumor (Fig. 2). Axial T1-weighted and Gd-enhanced 
magnetic resonance imaging (MRI) revealed a well-
circumscribed, low-signal-intensity mass situated in the 
right frontal, ethmoid, and sphenoid sinuses. Coronal 
T2-weighted MRI showed a low- to high-signal-density 
mass extending from the right frontal, ethmoid, and 
sphenoid sinuses to the intracranial frontal lobe; the 
mass had the appearance of a brain abscess (Fig. 3). 
Laboratory tests showed the following: leukocyte count, 
4660/μL; hemoglobin, 12.8 g/dL; C-reactive protein, 
0.17 mg/dL; LDH, 309 IU/L; soluble IL-2 receptor, 394 
U/mL; serum creatine, 1.31 mg/dL; anti-neutrophil cy-
toplasmic antibodies, negative; and Epstein-Barr virus 
(EBV)-DNA, below the detectable level. Endoscopic 
sinus surgery and biopsy of the tissue from the nasal 
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Fig. 1. This endoscopic view shows the white-coated mass in the 
right nasal cavity.
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mass were performed under general anesthesia for a 
definitive diagnosis. A soft, easily bleeding, white-
coated mass occupied the area between the middle and 
inferior turbinates. To avoid cerebrospinal leakage (CSF), 
the occupied lesion was removed with piece by piece 
under intraoperative navigation system and admitted to 
pathological examination. Pulsative purulent discharge 
in the frontal sinus was observed. The wall of the 
frontal sinus was partially damaged and the location of 
this area was confirmed at the lower portion of the brain 
abscess with intraoperative navigation system. Brain 
abscess was drained through the frontal sinus. CSF was 
not observed and bacterial culture of drained purulent 
discharge was negative, however, high dose systemic 
chemotherapy (Cefotax: 1.5g/day) was performed for 10 
days to prevent meningitis after surgical manipulation. 
The surgical specimen contained a dense polymorphic 
cell infiltrate consisting of histiocytes and a great num-
ber of atypical lymphoid cells. These atypical cells had 
large nuclei and were hyperchromatic; some of them 
had abnormal mitotic figures. Immunohistochemically, 
the tumor cells were positive for CD3, CD56, and EBV-
encoded small RNA (EBER), but negative for CD20 (Fig. 
4). The clinical and histological features were consistent 
with a diagnosis of primary extranodal nasal-type 
NK/T-cell lymphoma, stage IE. The patient received 
intensity-modulated radiotherapy to the nasofrontal area 
and part of the intracranial region (50 Gy) over 5 weeks. 
Fig. 2. Coronal and axial computed tomography shows a soft-tissue-density mass in the right frontal, maxillary, sphenoid, and ethmoid 
sinuses and the right nasal cavity. The orbital medial wall, nasal septum, and frontal skull base have been destroyed by the tumor.
Fig. 3. Axial T1-weighted and Gd-enhanced magnetic resonance images show a well-circumscribed, low-signal-intensity mass situated 
in the right frontal, ethmoid, and sphenoid sinuses. Coronal T2-weighted magnetic resonance images show a low- to high signal-density 
mass extending from the right frontal, ethmoid, and sphenoid sinuses to the intracranial frontal lobe.
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After radiotherapy, the patient received three courses of 
DeVIC chemotherapy (carboplatin 200 mg/m2, etopo-
side 67 mg/m2, ifosfamide 1 g/m2, and dexamethasone 
40 mg). The clinical course was satisfactory, and 72 
months after the initial treatment the patient is well, 
with no evidence of tumor.
DISCUSSION
To our knowledge, this is the first report of a primary 
extranodal nasal-type NK/T-cell lymphoma with 
brain abscess as the initial clinical manifestation. 
The mechanism underlying the brain abscess in this 
case was blockage of the frontal rescess by the tumor 
expanding from the nasal cavity over a long period of 
time. In spite of repeated biopsy out-patient basis, de-
finitive diagnosis could not be obtained, and endoscopic 
surgery was performed under general anesthesia with 
intraoperative navigation system. For making diagnosis 
precisely, enough volume of surgical specimen was 
mandatory, however, endoscopic surgery for this case 
was still challenging because of the narrow working 
space, the angled, anatomically variable frontal recess, 
and the proximity to the orbital tissue, olfactory fossa, 
and anterior skull base. Intraoperative navigation 
system was useful tool to identify the location. To 
prevent meningitis, high dose systemic chemotherapy 
was performed, and the cefotax was selected for this 
case because of pharmacodynamics of this agent with 
high delivery rate to brain tissues. The current World 
Health Organization (WHO) classification includes 
two types of NK/T-cell lymphoma: extranodal nasal-
type NK/T-cell lymphoma and aggressive NK-cell 
leukemia.1, 2 These diseases are mostly endemic to 
Latin America and East Asian countries. EBV is usually 
detected in the tumor cells, suggesting that it plays an 
important role in lymphomagenesis.1–5 In terms of site 
of origin, extranodal NK/T-cell lymphoma can be di-
vided into two major subtypes: nasal and extra-nasal.3, 4 
In advanced cases of both subtypes a highly aggressive 
clinical course and poor prognosis have been re-
ported.1, 2, 6 Extranodal nasal-type NK/T-cell lymphoma 
is rare, and P-glycoprotein, which is a product of the 
multi-drug resistance (MDR1) gene, is expressed on 
neoplastic cells of extranodal NK/T-cell lymphoma 
or aggressive NK-cell leukemia.2, 6–8 This expres-
sion is a major cause of the ref ractor iness of 
NK/T-cell lymphoma to conventional chemothera-
peutic regimens containing anthracycline. Although 
several case series indicate that the disease has an 
aggressive pattern and overall poor prognosis, DeVIC 
or a new chemotherapeutic regimen called SMILE 
(steroid, methotrexate, ifosfamide, L-asparaginase, 
Fig. 4. Histologic sections showing a dense polymorphic cell infiltrate consisting of histiocytes and a large number of atypical 
lymphoid cells. The atypical lymphoid cells have large nuclei and are hyperchromatic; some of them have abnormal mitotic figures. 
Immunohistologically, the tumor cells were positive for CD3, CD56, and EBER (a, HE; b, CD3; c, CD56; d, EBER). Bar = 100 μm.
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and etoposide) has recently showed promising results 
for extranodal nasal-type NK/T-cell lymphoma.1, 2, 6–8 
The amount of EBV-DNA in whole blood was useful 
for predicting tumor response, toxicity, and prognosis, 
and for monitoring during follow-up after DeVIC or 
SMILE chemotherapy.1, 2, 6–8 For patients with primary 
extranodal nasal-type NK/T-cell lymphoma of stage 
IE or contiguous stage IIE with cervical lymph node 
involvement, concurrent chemotherapy with radiation 
and DeVIC chemotherapy has recently been recom-
mended as a first-line treatment.2, 6–8 Recent studies 
have also found that SMILE is effective for extranodal 
nasal-type NK/T-cell lymphoma, but considering the 
strong myelotoxicity of this modality its use in treating 
primary extranodal nasal-type NK/T-cell lymphoma 
needs some modification.6, 7 In our patient, radiotherapy 
was performed as an induction therapy before DeVIC 
chemotherapy from the general conditions of patient 
and risk of side effects of combined therapy. The result 
supports the effectiveness of DeVIC for primary extra-
nodal nasal-type NK/T-cell lymphoma. The highly ag-
gressive course, with poor response and short survival 
with standard therapies, has led some investigators 
to recommend consolidation with bone- marrow or 
peripheral-stem-cell transplantation to prevent various 
chemotherapy-related complications.1, 2 Clearly, new 
and better treatment modalities are needed for primary 
extranodal nasal-type NK/T-cell lymphomas; these will 
likely incorporate radiation therapy.
In conclusion , we have presented an ex-
tremely rare case of primary extranodal nasal-type 
NK/T-cell lymphoma complicated by brain abscess. 
Primary extranodal nasal-type NK/T-cell lymphoma 
should be kept in mind in the work-up of brain abscess, 
which itself can give rise to various life-threatening 
complications.
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